ADGM ADAGIO MED HLDGS INC revenue, earnings and financials
For the quarter ended June 30, 2026, ADAGIO MED HLDGS INC reported revenue of $0, net income of −$6.72M and diluted EPS of −$0.30; over the last four quarters revenue was $0 and net income −$27.1M; for the fiscal year ended December 2025 revenue was $0, down 100.0% on the year before.
ADGM annual revenue and earnings
- Fiscal year ended Dec 2025: revenue $0, gross profit n/a, operating income −$21.9M, net income −$25.1M (margin n/a), EPS −$1.51
- Fiscal year ended Dec 2023: revenue $300K, gross profit n/a, operating income −$27.9M, net income −$36.6M (margin -12196.7%), EPS −$48.16
ADGM quarterly revenue and earnings
- Quarter ended Jun 30, 2026: revenue $0, net income −$6.72M, EPS −$0.30
- Quarter ended Mar 31, 2026: revenue $0, net income −$7.00M, EPS −$0.31
- Quarter ended Dec 31, 2025 (from the annual report): revenue $0, net income −$3.31M, EPS $0.01
- Quarter ended Sep 30, 2025: revenue $0 (down 100.0% year over year), net income −$10.1M, EPS −$0.66
- Quarter ended Jun 30, 2025: revenue $0 (down 100.0% year over year), net income −$3.95M, EPS −$0.35
- Quarter ended Mar 31, 2025: revenue $0 (down 100.0% year over year), net income −$7.71M, EPS −$0.51
- Quarter ended Sep 30, 2024: revenue $132K (up 222.0% year over year), net income $3.61M, EPS $0.02
- Quarter ended Jun 30, 2024: revenue $254K, net income −$5.73M, EPS −$7.35
- Quarter ended Mar 31, 2024: revenue $26.0K, net income −$8.02M, EPS −$10.28
- Quarter ended Sep 30, 2023: revenue $41.0K, net income −$10.8M, EPS −$14.15
ADGM cash flow, buybacks and dividends
- Fiscal year ended Dec 2025: operating cash flow −$19.0M, share buybacks n/a
- Fiscal year ended Dec 2023: operating cash flow −$25.7M, share buybacks n/a, dividends $0.00 per share
ADGM balance sheet
- Jun 30, 2026: cash $7.74M, total assets $33.9M, total liabilities $34.3M, shareholders' equity −$415K
- Mar 31, 2026: cash $12.9M, total assets $39.3M, total liabilities $33.6M, shareholders' equity $5.73M
- Dec 31, 2025: cash $17.1M, total assets $43.3M, total liabilities $30.9M, shareholders' equity $12.4M
- Sep 30, 2025: cash $4.67M, total assets $31.5M, total liabilities $32.9M, shareholders' equity −$1.31M
- Jun 30, 2025: cash $8.20M, total assets $35.9M, total liabilities $27.2M, shareholders' equity $8.67M
- Mar 31, 2025: cash $13.0M, total assets $41.3M, total liabilities $28.9M, shareholders' equity $12.4M
- Dec 31, 2024: cash $20.6M, total assets $48.4M, total liabilities $28.5M, shareholders' equity $19.9M
- Sep 30, 2024: cash $28.3M, total assets $107M, total liabilities $30.6M, shareholders' equity $76.6M
What is ADGM's revenue?
ADAGIO MED HLDGS INC reported $0 of revenue over its last four quarters, through June 30, 2026.
Is ADGM profitable?
No. ADAGIO MED HLDGS INC lost $27.1M over the last four quarters.
What is ADGM's EPS?
Diluted earnings per share over the last four quarters were −$1.26; −$0.30 in the latest quarter.